ALNOV:EPA
Novacyt SA
0,44 €
arrow_upward
+1,38%(+0,0060) 1D
18 նոյ, 10:08:47 GMT+1 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ALNOV...
Open
0,44 €
High
0,44 €
Low
0,43 €
Mkt. cap
31,93 մլն
Avg. vol.
139,48 հզր
Volume
4,31 հզր
52-wk high
1,04 €
52-wk low
0,29 €
EPS
-0,38 €
Shares outstanding
72,59 մլն
No. of employees
228
Open
0,44 €
High
0,44 €
Low
0,43 €
Mkt. cap
31,93 մլն
Avg. vol.
139,48 հզր
Volume
4,31 հզր
52-wk high
1,04 €
52-wk low
0,29 €
EPS
-0,38 €
Shares outstanding
72,59 մլն
No. of employees
228
News stories
From web sources and news partners
Yahoo Finance
·
34 րոպե առաջ
Stock market today: Dow, S&P 500, Nasdaq futures rise after Nvidia clears hurdle, Anthropic prepares to price its IPO
MarketWatch
·
50 րոպե առաջ
The S&P 500 just broke a crucial support level. Here’s what history shows may happen now.
MarketWatch
·
1 ժամ առաջ
Stock Market Today: Dow, S&P 500 and Nasdaq set to climb as Nvidia shares rise after boosting guidance; Anthropic expected to price IPO: live updates
www.tokenpost.com
·
24 րոպե առաջ
Nasdaq Gains 0.91% as S&P 500 Futures and Dow Also Advance
Profile
Novacyt Group is an Anglo-French biotechnology group focused on clinical diagnostics, with offices in Camberley, Surrey, United Kingdom and Vélizy-Villacoublay, France. The company produces in vitro and molecular diagnostic tests, supplying assays and reagents worldwide. Its business units include Primerdesign, Microgen Bioproducts and Lab21 Healthcare.
In January 2020 the company announced that its molecular diagnostics division, Primerdesign, had launched a molecular test for the 2019 strain of SARSr-CoV. The test was approved as eligible for procurement under the World Health Organization's Emergency Use Listing process in April 2020, meaning that the test could be supplied by the United Nations and other procurement agencies supporting the COVID-19 response. In the same month Novacyt announced a collaboration with AstraZeneca, GlaxoSmithKline and the University of Cambridge to support the UK in its COVID-19 national screening programme at a new testing laboratory at the university's Anne McLaren laboratory. Wikipedia
About Novacyt SA
CEODavid Allmond
Employees228
Founded03 հլս, 2006 թ.
Headquarters-
SectorHealth Care
Industry-
Websitenovacyt.com